Kenya: New ARV Drug Rolled Out to Reduce HIV Treatment Side Effects

Nairobi — The Ministry of Health has rolled out a new ARV first-line drug that can improve and prolong lives of thousands of people living with HIV who suffer severe side effects and resistance to treatment.

The new drug Dolutegravir (DTG), a generic version will first be administered to 27,000 patients in Kenya before being rolled out in Uganda and Nigeria later this year.

...

AllAfrica publishes around 400 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.